Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Tüting

Showing results (51-60 of 154) with videos related to

Pageof 16
Sort By:
Journal of the American Academy of Dermatology|March 21, 2007
CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundusJoerg Wenzel, Julia Proelss, Andreas Wiechert, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 12, 2022
Persistent facial swellingMiriam Mengoni, Freya-Sophie Lenz, Andreas Dominik Braun, et al.
The American Journal of Pathology|December 7, 2007
Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation?Marina Scheler, Joerg Wenzel, Thomas Tüting, et al.
Journal of the American Academy of Dermatology|April 19, 2011
Enhanced skin expression of melanoma differentiation-associated gene 5 (MDA5) in dermatomyositis and related autoimmune diseasesSabine Zahn, Winfried Barchet, Claudia Rehkämper, et al.
Scientific Reports|April 12, 2016
A stochastic model for immunotherapy of cancerMartina Baar, Loren Coquille, Hannah Mayer, et al.
Journal of the American Academy of Dermatology|August 23, 2005
The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoidesJoerg Wenzel, Ines Gütgemann, Moritz Distelmaier, et al.
Melanoma Research|January 6, 2016
Overexpression of hepatocyte growth factor and an oncogenic CDK4 variant in mice alters corneal stroma morphology but does not lead to spontaneous ocular melanomaMarta M Kilian, Martina C Herwig, Frank G Holz, et al.
Dermatologie (Heidelberg, Germany)|August 14, 2024
[Sarcopenia and immune-related toxicity in patients with malignant melanoma undergoing immune checkpoint inhibition]Christian Holtorf, Miriam Mengoni, Thomas Tüting, et al.
Journal of Cancer Research and Clinical Oncology|May 25, 2024
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockadeMiriam Mengoni, Andreas Dominik Braun, Mattes Simon Hinnerichs, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 10, 2024
Comprehensive analysis of body composition features in melanoma patients treated with tyrosine kinase inhibitorsMiriam Mengoni, Andreas Dominik Braun, Mattes Simon Hinnerichs, et al.
Pageof 16

Showing results (51-60 of 154) with videos related to

Sort By:
Pageof 16
Journal of the American Academy of Dermatology|March 21, 2007
CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundusJoerg Wenzel, Julia Proelss, Andreas Wiechert, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 12, 2022
Persistent facial swellingMiriam Mengoni, Freya-Sophie Lenz, Andreas Dominik Braun, et al.
The American Journal of Pathology|December 7, 2007
Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation?Marina Scheler, Joerg Wenzel, Thomas Tüting, et al.
Journal of the American Academy of Dermatology|April 19, 2011
Enhanced skin expression of melanoma differentiation-associated gene 5 (MDA5) in dermatomyositis and related autoimmune diseasesSabine Zahn, Winfried Barchet, Claudia Rehkämper, et al.
Scientific Reports|April 12, 2016
A stochastic model for immunotherapy of cancerMartina Baar, Loren Coquille, Hannah Mayer, et al.
Journal of the American Academy of Dermatology|August 23, 2005
The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoidesJoerg Wenzel, Ines Gütgemann, Moritz Distelmaier, et al.
Melanoma Research|January 6, 2016
Overexpression of hepatocyte growth factor and an oncogenic CDK4 variant in mice alters corneal stroma morphology but does not lead to spontaneous ocular melanomaMarta M Kilian, Martina C Herwig, Frank G Holz, et al.
Dermatologie (Heidelberg, Germany)|August 14, 2024
[Sarcopenia and immune-related toxicity in patients with malignant melanoma undergoing immune checkpoint inhibition]Christian Holtorf, Miriam Mengoni, Thomas Tüting, et al.
Journal of Cancer Research and Clinical Oncology|May 25, 2024
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockadeMiriam Mengoni, Andreas Dominik Braun, Mattes Simon Hinnerichs, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 10, 2024
Comprehensive analysis of body composition features in melanoma patients treated with tyrosine kinase inhibitorsMiriam Mengoni, Andreas Dominik Braun, Mattes Simon Hinnerichs, et al.
Pageof 16